Infectivity of SARS-CoV-2: there Is Something More than D614G?,Journal of Neuroimmune Pharmacology

当前位置： X-MOL 学术 › J. Neuroimmune Pharmacol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Infectivity of SARS-CoV-2: there Is Something More than D614G?
Journal of Neuroimmune Pharmacology ( IF 6.2 ) Pub Date : 2020-09-15 , DOI: 10.1007/s11481-020-09954-3
Saathvik R Kannan _{1,

2} , Austin N Spratt _{1,

3} , Thomas P Quinn ₄ , Xiao Heng ₄ , Christian L Lorson _{1,

5} , Anders Sönnerborg _{6,

7} , Siddappa N Byrareddy ₈ , Kamal Singh _{1,

5,

7,

9,

10}

Affiliation

Bond Life Sciences Center, University of Missouri, Columbia, MO, 65211, USA.
Hickman High School, Columbia, MO, 65203, USA.
Department of Mathematics, University of Missouri, Columbia, MO, 65211, USA.
Department of Biochemistry, University of Missouri, Columbia, MO, 65211, USA.
Department of Veterinary Pathobiology, University of Missouri, Columbia, MO, 65211, USA.
Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, MO, 65211, USA.
Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, Huddinge, 14186, Stockholm, Sweden.
Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Centre, Omaha, NE, 68198, USA.
Shift Pharmaceuticals, Overland Park, KS, 66211, USA.
Sanctum Therapeutics Corporation, Sunnyvale, CA, 94087, USA.